MRO
55
3
MA
55
-7
EW
37
-2
EL
20
3
SRE
63
-3
GRMN
62
-3
VLO
40
-2
AMP
69
-3
CVS
48
3
DG
2
-6
CSX
51
-2
DVA
72
2
PBI
60
-5
BMY
53
-7
MKC
56
8
NWSA
62
2
MTCH
37
7
HP
38
-2
KMX
58
3
AIG
38
-4
MRO
55
3
MA
55
-7
EW
37
-2
EL
20
3
SRE
63
-3
GRMN
62
-3
VLO
40
-2
AMP
69
-3
CVS
48
3
DG
2
-6
CSX
51
-2
DVA
72
2
PBI
60
-5
BMY
53
-7
MKC
56
8
NWSA
62
2
MTCH
37
7
HP
38
-2
KMX
58
3
AIG
38
-4
Financhill
Back

Blueprint Medicines Vs. Recursion Pharmaceuticals Industry Stock Comparison

Sell
37

BPMC
Blueprint Medicines

Last Price:
94.81
Seasonality Move:
-0.18%
Sell
48

RXRX
Recursion Pharmaceuticals

Last Price:
6.04
Seasonality Move:
6.36%
Sell
37
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $94.81. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $6.04. The Score for RXRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $94.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $6.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.39 Buy
Relative Strength Index (14 RSI): 54.43 Buy
Chaikin Money Flow: 456578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.11 - 97.25) Buy
Bollinger Bands (100): (85.77 - 106.49) Sell

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 40.35 Sell
Chaikin Money Flow: 241279 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.29 - 7.17) Sell
Bollinger Bands (100): (6.28 - 7.64) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.66 Buy
20-day SMA: 92.39 Buy
50-day SMA: 90.02 Buy
200-day SMA: 95.85 Sell
8-day EMA: 94.12 Buy
20-day EMA: 93.09 Buy
50-day EMA: 92.24 Buy
200-day EMA: 91.11 Buy

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.78 Sell
20-day SMA: 6.73 Sell
50-day SMA: 6.65 Sell
200-day SMA: 8.36 Sell
8-day EMA: 6.5 Sell
20-day EMA: 6.66 Sell
50-day EMA: 6.75 Sell
200-day EMA: 7.72 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.19 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):